October Is a Huge Month for Social Security. Look Out for These 3 Big Announcements
Key PointsOctober is when the Social Security Administration typically announces key changes to the program.
Nasdaq News
Zealand Pharma: Boehringer's Survodutide Meets Phase 3 Endpoints In Obesity & Diabetes Trial
(RTTNews) - Zealand Pharma A/S (ZEAL.CO) said Thursday that Boehringer Ingelheim's investigational Survodutide met its co-primary endpoints in the Phase 3 SYNCHRONIZE-2 trial in adults with obesity or overweight and type 2 diabetes.
Kia America September Sale Rises By 18%
(RTTNews) - Kia Corporation (000270.KS), a South Korean automobiles manufacturer, Thursday said that its American subsidiary, reported higher September vehicle sales compared to the same period last year.
Genentech's Giredestrant Posts Positive Phase 3 Data Ahead Of November, December FDA Dates
(RTTNews) - Genentech, a member of the Roche Group (RHHBY), announced that detailed Phase 3 evERA study results published in the New England Journal of Medicine showed that giredestrant combined with everolimus significantly improved progression-free survival in patients with ER-
Michael Burry's New Bet Against Micron Stock Expires in June 2027. I Think His Timing Is Off.
Key PointsMichael Burry replaced his Micron short position with put options that expire in June 2027.
Lundbeck's Phase IV Trial Of Eptinezumab Meets Primary Goal In Migraine After Prior CGRP Therapy
(RTTNews) - H. Lundbeck A/S (HLBBF), a biopharmaceutical company, announced positive results from the Phase IV THRIVE trial evaluating eptinezumab in adults with migraine who had an inadequate response to one prior calcitonin gene-related peptide (CGRP)-targeting preventive thera
If I Had $10,000 to Invest Today, Here's the Growth Stock I'd Buy Instead of SpaceX
Key PointsElon Musk's Space Exploration Technologies (SpaceX) went public in June, and it has already lost 34% of its peak value.
Novacyt H1 Loss Narrows As Revenue Rises 18%
(RTTNews) - Novacyt S.A. (NCYT.L), a diagnostics company providing molecular testing technologies and services, reported higher revenue and a narrower loss for the six months ended June 30, 2026.
Bassett Furniture Shares Up On Higher Q3 Results, Positive Outlook
(RTTNews) - Shares of Bassett Furniture Inc. (BSET) gained around 10 percent in the after-market activity on the Nasdaq after the company reported higher profit in the third quarter of fiscal 2026, supported by increased revenue, expense control and tariff refunds.
Pfizer's Tilrekimig Meets Phase 2 Primary Endpoint In Atopic Dermatitis
(RTTNews) - Pfizer Inc. (PFE) reported Thursday that its ongoing Phase 2 study of investigational Tilrekimig met its primary endpoint in adults with moderate to severe atopic dermatitis.
If a Stock Market Crash Is Coming, History Says the Smartest Investors Are All Making the Same Move
Key PointsThe market has been reaching record highs, despite multiple headwinds.
Lundbeck Reports Positive Phase IV THRIVE Results For Eptinezumab In Migraine
(RTTNews) - H. Lundbeck A/S (HLBBF) announced headline results from the Phase IV THRIVE trial evaluating eptinezumab, an investigational humanised monoclonal antibody administered intravenously, in adults with migraine who had an inadequate response to one prior CGRP-targeting pr
Roche Highlights Real-World Vabysmo Performance Across Major Retinal Diseases At EURETINA
(RTTNews) - Roche (RHHBY) announced new data from the VOYAGER study showing that Vabysmo (faricimab) continued to demonstrate effectiveness, durability and safety in real-world clinical practice across several major retinal diseases.
If I Could Tell Every New Investor 1 Thing About Building Wealth in the Stock Market, It's This
Key PointsA bull market is a great time to own stocks, as many may soar and will increase the value of your portfolio.
Tevogen Regains Nasdaq Listing Compliance; Stock Up
(RTTNews) - Tevogen Inc. (TVGN), a healthcare company, said it received notice from Nasdaq on September 29, 2026, confirming that it had regained compliance with the $50 million minimum market value of listed securities requirement for continued listing on the Nasdaq Global Marke
Amazon Stock Pays $0 in Dividends. Here's Why Long-Term Investors Should Own It Anyway.
Key PointsCompeting in AI has come with tremendous demands for capital spending.
Roche Says Giredestrant- Everolimus Combo Significantly Improves PFS In ER+ Breast Cancer
(RTTNews) - Swiss drug major Roche Holding AG (RHHBY, RO.SW, ROG.SW) announced Thursday that giredestrant combination significantly improved progression-free survival in ER-positive advanced breast cancer in phase III evERA.
Roche's Vabysmo Shows Real-World Effectiveness Across Retinal Diseases
(RTTNews) - Thursday, Roche (RHHBY) reported new data from the VOYAGER study showing that Vabysmo (faricimab) delivered durable effectiveness and a consistent safety profile in patients with wet age-related macular degeneration (AMD), diabetic macular edema (DME) and macular edem
Sanofi, Regeneron Expand Immunology Alliance In Deal Worth Up To $8 Bln
(RTTNews) - Sanofi (SNY) and Regeneron Pharmaceuticals (REGN) on Thursday announced an expanded global collaboration to develop and commercialise four next-generation, long-acting immunology antibodies targeting type 2 inflammation.
Weak Sentiment Expected In European Markets On Thursday
(RTTNews) - Sentiment in European stock markets is expected to remain weak on Thursday amidst a hardening in global bond yields. Ten-year bond yields have increased more than a quarter percent in Germany, France, U.K., as well as Spain. The easing in crude oil prices, the momentu
This feed is responsible for generating the rss feed related to the topic latest article
Subscribe to Nasdaq News feed